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Abstract
Background: The phenotype in patients with a 22q11.2 deletion or duplication can be extremely variable, and the
causes of such as variations are not well known.
Results: We observed additional copy number variations (CNVs) in 2 of 15 cases with a 22q11.2 deletion or
duplication. Both cases were newborn babies referred for severe congenital heart defects. The first case had a
deletion with a size of approximately 1.56 Mb involving multiple genes including STS in the Xp22.31 region along
with a 22q11.2 deletion. The second case had a duplication of 605 kb in the 15q13.3 region encompassing
CHRNA7 and a deletion of 209 kb involving the RBFOX1 gene in the 16p13.2 region, in addition to 22q11.2
duplication.
Discussion: Our observations have shown that additional CNVs are not rare (2/15, 13%) in patients with a 22q11.2
deletion or duplication. We speculate that these CNVs may contribute to phenotype variations of 22q11.2
microdeletion/duplication syndromes as genomic modifiers.
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Background
It is well known that the phenotype of patients with
22q11.2 microdeletion or microduplication can be extre-
mely variable from near normal to severe developmental
disabilities including congenital heart defects, learning
disabilities, and risk of psychological problems such as
attention-deficit hyperactivity disorder, autism-spectrum
disorders and schizophrenia [1,2]. The mechanisms that
lead to extreme phenotype variations in this syndrome
remain unknown. Prior to the clinical use of microarray
based comparative genomic hybridization (array CGH),
vast majority of patients with a 22q11.2 deletion or
duplication were diagnosed by FISH [3-5], and therefore
genomic changes other than the 22q11.2 region were
barely known. Here, we report additional genomic aber-
rations detected by array CGH in two newborns, one




The patient was an infant girl, 15 days of age, born to a
23 year old healthy mother. The baby was delivered at
the 38th week of gestation by C-section due to nuchal
cord. The baby weighted 2.9 kg, with Apgar scores 8 at
1 min, 9 at 5 min, and 9 at 10 min. Management of the
infant at delivery included stimulation and suction. Echo-
cardiography showed tetralogy of Fallot with absent pul-
monary valve and left hemitruncus. A computerized
tomography (CT) scan of the thorax with contrast and
3D reconstruction showed a large right pulmonary artery
compressing on both right and left main stem bronchi,
but more significantly on the right bronchi during sys-
tole. The infant also had mild respiratory distress at
birth, anemia, and feeding intolerance. She became
increasingly tachypneic with chest X-ray findings of air
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trapping on the right lung, pulmonary edema on the left
lung, and cardiomegaly. Abdominal ultrasound showed
bilateral small kidneys. Other physical and ultrasound
examinations were unremarkable, except for overriding
toes.
Patient 2
Patient 2 was an infant boy, 15 days of age. He was deliv-
ered at 37th week of gestation to a 19-year-old mother by
C-section due to IUGR. His birth weight was 2.25 kg with
Apgar scores of 9, 9 and 9. No complications were
reported in the mother during this pregnancy. The baby
had normal tone and reflexes with apparently normal
activities. He had micrognathia without other specific dys-
morphic features. Systolic ejection murmur at the lower
sternal border was noted. Ultrasound showed complex
congenital heart defects including double outlet right ven-
tricle with a large ventricular septal defect and pulmonary
stenosis, mild right ventricular hypertrophy, mild tricuspid
valve hypoplasia, pulmonary valve hypoplasia, and patent
foramen ovale with bidirectional shunting. Other obvious
abnormalities were not noted by physical examinations
and routine laboratory tests. The maternal side of the
family had a history of controlled hypertension and heart
murmur without complications while the paternal side
history was unremarkable.
Results
In patient 1, array CGH showed a 2.47 Mb deletion in the
22q11.2 region and a 1.56 Mb deletion in the Xp22.31
region (Figure 1A). In patient 2, array CGH detected
multiple CNVs, including a 2.84 Mb duplication in the
DiGeorge region, a 605 kb duplication in the 15q13.3
region and a 209 kb deletion in the 16p13.2 region (Fig-
ure 1B). Details of the CNVs in the two patients are sum-
marized in Table 1. Conventional chromosome analysis
revealed a normal karyotype in both patients. Parental
studies were offered to the parents of both proband
patients but were declined.
Discussion
22q11.2 microdeletion and microduplication syndromes
are mediated by nonallelic homologous recombination
(NAHR) between region-specific low-copy repeats (LCRs)
during meiosis [6]. The number of patients with a micro-
duplication appears to be smaller than that of patients
with a deletion although an equal frequency is expected
[7,8]. We have detected microdeletion or microduplication
of the 22q11.2 DiGeorge region in 15 of 1292 cases
(1.16%) referred for intellectual disabilities and/or congeni-
tal anomalies in the past several years. Among them, ten
patients had a 2.4 Mb ~ 2.9 Mb deletion; two patients had
a duplication of the same region; one had a 1.4 Mb dele-
tion and two had a 500-600 Kb duplication.
A DNA segment with a size of approximately 3 Mb that
encompasses over 40 functional genes is involved in about
90% of 22q11.2 microdeletions or microduplications [2].
Clinical features of congenital heart defects in 22q11.2
deletion syndromes are usually associated with the com-
mon 3 Mb deletions involving TBX1, while atypical dele-
tions may show variable phenotypes modified by deletion
location, size and other factors [9,10]. However, extremely
variable phenotypes have been reported in patients with
the same 22q11.2 deletion, and the mechanisms leading to
such variations remain unknown [11].
We detected complex CNVs in 2 of the 15 cases (13%),
suggesting that additional CNVs are not rare among the
patients with a 22q11.2 microdeletion or microduplica-
tion. Our patient 1 had an Xp22.31 deletion involving
HDHD1A, STS, VCX, PNPLA4 genes in addition to the
typical 22q11.2 deletion. STS deletion is associated with
X-linked ichthyosis (XLI) in male due to deficiency of
steroid sulfatase (STS) activity [12]. We speculate that the
genes involved in Xp22.3 and 22q11.2 deletions may
interact in normal development given the large number
of genes involved.
Our patient 2 had a duplication of the CHRNA7 gene
on chromosome 15q and a partial deletion of the
RBFOX1 gene on chromosome 16p in addition to the
22q11.2 duplication. The microduplication phenotypes
can be very different even within the same family with
the exactly same duplication [6]. While the majority of
patients with a 22q11.2 deletion have congenital heart
defects, most of the cases with duplication of this region
do not have [6]. Our patient 2 had severe congenital
heart defect. It is not known if the additional CNVs have
contributed to the severe abnormal heart development in
this patient, but this possibility cannot be excluded. It is
well known that neuropsychiatric disorders such as schi-
zophrenia, attention deficit disorder, depression and aut-
ism frequently occur in the individuals with a 22q11.2
deletion or duplication [13-15]. Copy number variations
of CHRNA7 and RBFOX1 have been reported in patients
with mental retardation, autism and schizophrenia or sei-
zure [16-18]. It is likely that CNVs of CHRNA7 and
RBFOX1 would add additional risk for psychological dis-
eases in the patient when he grows up.
Conclusions
In summary, the observation of additional CNVs in our
two cases with 22q11.2 microdeletion/duplication suggests
that complex genomic changes are not rare in DiGeorge
patients and they may, as genomic modifiers, contribute to
the variable phenotypes of the disease. Continuing follow-
up with these two patients and accumulation of more
cases similar to ours in literature may help our under-
standing on the complicated phenotypes of the 22q11.2
microdeletion/duplication syndrome.
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Materials and methods
Chromosome analysis
Conventional GTG banded chromosome analysis was
performed at the level of resolution of 500-550 bands
per hypoid and reported according to ISCN 2009.
Array CGH
Array CGH was performed as described [19]. Briefly, DNA
was extracted from patient peripheral blood using
commercially available DNA isolation kits (Qiagen
Sciences, Maryland) according to the manufacturer’s
instructions. A customized genome-wide oligonucleotide
array (Agilent Technologies, Santa Clara, CA) was used
for the studies. This platform was composed of 44,290 60-
mer oligonucleotide probes with an average spacing of 30-
35 kb genome-wide. Probes are enriched for the regions
and genes known to be associated with syndromes or
developmental disorders. Patient and reference DNA
Figure 1 Complex pathogenic imbalances in two patients. A. A 2.47 Mb deletion at 22q11.21 and a 1.56 Mb deletion at Xp22.31 in patient 1.
B. A 2.84 Mb duplication at 22q11.21, a 0.61 Mb duplication at 15q13.3, and a 0.21 Mb deletion at 16p13.2 in patient 2.
Table 1 CNVs involved in the two patients (hg18)
Patient Imbalance Size (MB) ISCN description Genes involved
1 del 2.47 22q11.21(17299942-19770514) × 1 More than 40 genes
including TBX1
del 1.56 Xp22.31(6498721-8057511) × 1 HDHD1A, STS, VCX, PNPLA4
2 dup 2.84 22q11.21(17299942-20139009) × 3 More than 40 genes
including TBX1
dup 0.605 15q13.3(29818304-30423251) × 3 CHRNA7
del 0.209 16p13.2(6776911-6986220) × 1 RBFOX1
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samples were differentially labeled and cohybridized to the
arrays. Hybridized slides were scanned with microarray
scanner (Agilent G2505B), and analyzed with Feature
Extraction and DNA Analytics 4.0 (Agilent Technologies).
The assembly hg18/build36 of the human genome was
used for the two cases.
Consent
All patients under the care of Jackson Memorial Hospi-
tal (JMH) signed a written informed consent that allows
the medical staff of JMH and University of Miami
School of Medicine to use their medical records for
medical research and education purpose without reveal-
ing patient identification. A copy of the written consent
is available to review by the Editor-in-Chief of this
journal.
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